General Motors
GM
$78.71
-3.72%
General Motors is a legacy global automaker that designs, manufactures, and sells vehicles across its four U.S. brands (Chevrolet, GMC, Buick, Cadillac) plus international operations, organized into GM North America, GM International, and the captive-lending arm GM Financial; it also holds a controlling interest in the Cruise autonomous-vehicle business. GM is a scale incumbent rather than a disruptor — it reclaimed U.S. market-share leadership in 2022 and posted 17.4% U.S. share in 2025 (up 60 bps), competing against Toyota, Ford, Stellantis, and a rising wave of EV entrants. The current investor narrative centers on capital return and cash generation rather than volume growth: management's new $20 billion buyback authorization (following a ~40% share-count reduction since 2023) and raised free-cash-flow guidance have reframed GM as a value-and-return story, with bulls citing a total shareholder yield near 12.6% versus Ford's ~5.7%. Offsetting that enthusiasm are near-term commodity/tariff headwinds, a Q4 2025 loss driven by a large non-cash charge, and the strategic retreat from robotaxi operations toward personal autonomous vehicles — leaving the debate squarely on whether buybacks and software margins can offset cyclical auto earnings.…
GM
General Motors
$78.71
Related headlines
Investment Opinion: Should I buy GM Today?
Rating: Buy (accumulate on weakness). The core thesis is that GM is a cash-return compounder mispriced as a cyclical: a 5.35x forward PE on consensus EPS of ~$21.59 against a $78.71 price, $16.50 billion of TTM free cash flow, a new $20 billion buyback authorization, and a 20-Buy/4-Hold/0-Sell consensus with a $101.17 average target (+28.5% upside) together argue the market is discounting normalized earnings rather than reflecting them. The sell-side is directionally unanimous — mean rating 1.625, no Sell ratings, and reiterated Buy/Overweight actions from Morgan Stanley, RBC, Barclays, UBS, TD Cowen, and Goldman on October 21, 2026 — which anchors the view that the recent pullback is an entry point rather than a fundamental deterioration.
Supporting evidence is concrete: forward PE of 5.35x versus a 24.42x trailing multiple (the latter distorted by the Q4 2025 loss), 0.40x PS and 0.92x EV/Sales near the bottom of GM's own three-year PS band of roughly 1.0x-1.65x, and 9.99x EV/EBITDA consistent with a mature manufacturer at a cyclical discount. Revenue grew 2.93% YoY to $50.02 billion in Q3 2026 with an 18.55% gross margin and $3.34 billion of net income, a sharp rebound from Q2's 7.61% gross margin, while Q3 operating cash flow of $7.32 billion and free cash flow of $4.97 billion funded $2.50 billion of buybacks plus $215 million of dividends internally. The 12.6% total shareholder yield versus Ford's ~5.7%, backed by a ~40% share-count reduction since 2023, is the clearest quantitative differentiator in the peer set.
The biggest risks that could invalidate the thesis are (1) Q3's 18.55% gross margin proving a mix/timing artifact rather than a durable recovery — trailing gross margin is 10.86%, below the 12-14% range GM posted through much of 2023-2024; (2) commodity and tariff cost pressure compressing forward EPS below the ~$21.59 consensus, which would collapse the 5.35x multiple's apparent discount; and (3) 2.13x debt-to-equity plus a 1.418 beta leaving little cushion in a U.S. cyclical downturn, given GM North America contributed $41.42 billion of Q3's $50.02 billion. This Buy would upgrade to a higher-conviction stance if gross margin holds above 15% for a second consecutive quarter and price reclaims the mid-$80s, and would downgrade to Hold if gross margin reverts below 12% or consensus FY EPS is cut below ~$18. Valuation verdict: undervalued relative to GM's own history (0.40x PS versus a 1.0x-1.65x three-year band) and to its forward earnings power, though the $75 analyst low target sitting essentially at the current price means the margin of safety rests on earnings durability, not on the price level itself.
Sign up to view all
GM 12-Month Price Forecast
The forward-looking view is bullish but with medium rather than high confidence, because the valuation case is unusually strong while the earnings base it rests on is unusually volatile. At 5.35x forward earnings, 0.40x sales, and 0.92x EV/Sales, GM is priced for cyclical pessimism, and the $16.50 billion TTM free cash flow plus the $20 billion buyback authorization give management a mechanical EPS lever independent of volume growth. Analyst sentiment corroborates the direction — 20 of 23 analysts rate Buy, none rate Sell, and the $101.17 average target implies +28.5% upside — but the $75-$132 target range is a 76% spread that signals genuine disagreement about normalized earnings power, and the $75 low target sits essentially at the current price. The single swing factor is whether Q3's 18.55% gross margin is durable or a mix/timing artifact; a second consecutive quarter above 15% would justify upgrading confidence to high and pushing toward the bull case, while a reversion below 12% would validate the bear case and argue for a downgrade to neutral. Position sizing should reflect the 1.418 beta and the -16.2% max drawdown, since the fat-tailed outcome distribution means the low target offers no downside cushion.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on General Motors's 12-month outlook, with a consensus price target around $101.17 and implied upside of +28.5% versus the current price.
Average Target
$101.17
24 analysts
Implied Upside
+28.5%
vs. current price
Analyst Count
24
covering this stock
Price Range
$75 - $132
Analyst target range
Coverage is broad and decidedly bullish: 23 analysts rate the stock, with 20 Buy, 4 Hold, and 0 Sell, producing a consensus recommendation of "buy" and a mean rating of 1.625 (where 1.0 is a strong buy). The average target price of $101.17 implies roughly +28.5% upside from the $78.71 current price, a gap wide enough to suggest the sell-side views the recent pullback as an entry point rather than a deterioration in fundamentals. Institutional ratings corroborate the stance — Morgan Stanley, RBC, Barclays, UBS, TD Cowen, and Goldman Sachs all reiterated Buy/Overweight/Outperform actions on October 21, 2026, and Tigress Financial maintained a Strong Buy on October 28 — with no downgrades in the recent tape, indicating stable rather than shifting conviction. The target range is unusually wide, from $75.00 to $132.00 — a 76% spread around the $101.17 average — which signals genuine disagreement about normalized earnings power. The $132 high target likely assumes successful execution of the $20 billion buyback (compounding EPS through a shrinking share count), sustained high-margin software/services growth, and multiple re-rating toward book value or peer levels; the $75 low target sits essentially at the current price and the 52-week low, implying margin compression from commodity/tariff headwinds and skepticism that Q3's 18.55% gross margin is sustainable. The wide dispersion, combined with a beta of 1.418 and a 2.44 short ratio, means the consensus is directionally bullish but the outcome distribution is fat-tailed — position sizing should reflect that the low target offers essentially no downside cushion relative to where the stock trades today.
Bulls vs Bears: GM Investment Factors
The bull case currently has stronger evidence: a 5.35x forward PE, $16.50 billion of TTM free cash flow, a $20 billion buyback authorization, a 12.6% total shareholder yield, and a 20-Buy/4-Hold/0-Sell analyst consensus with +28.5% implied upside all point to a mispriced cash-return story. The bear case rests on genuine but secondary concerns — extreme quarterly margin volatility (7.61% to 18.55%), 2.13x debt-to-equity, commodity/tariff pressure, and a stock that has failed repeatedly in the low $90s. The single most important tension is whether Q3's 18.55% gross margin is a durable recovery or a favorable mix/timing artifact; if margins normalize toward the 10.86% trailing level, the forward EPS of ~$21.59 that justifies the 5.35x multiple collapses and the value thesis with it. Until price reclaims the mid-$80s and margin durability is confirmed over another quarter, the evidence favors the bulls on valuation but with position sizing that respects the fat-tailed outcome distribution.
Bullish
- Deep-value forward multiple at 5.35x: GM's forward PE of 5.35x (on consensus EPS of ~$21.59 against a $78.71 price) is a fraction of the 24.42x trailing multiple, which is inflated by the Q4 2025 loss. The 0.40x PS and 0.92x EV/Sales sit near the bottom of GM's own three-year PS band of roughly 1.0x-1.65x, implying the market is pricing cyclical pessimism rather than normalized earnings.
- Buyback machine drives EPS compounding: Management has cut the share count roughly 40% since 2023 and authorized a new $20 billion repurchase program, funded by $16.50 billion of TTM free cash flow rather than balance-sheet capacity. Q3 2026 alone saw $2.50 billion of buybacks plus $215 million of dividends, producing a total shareholder yield near 12.6% versus Ford's ~5.7%.
- Analyst consensus firmly bullish: Of 23 covering analysts, 20 rate Buy, 4 Hold, and 0 Sell, for a consensus 'buy' and mean rating of 1.625. The $101.17 average target implies +28.5% upside from $78.71, and Morgan Stanley, RBC, Barclays, UBS, TD Cowen, and Goldman all reiterated Buy/Overweight actions on October 21, 2026 with no recent downgrades.
- Cash generation remains robust: Q3 2026 operating cash flow was $7.32 billion with $4.97 billion of free cash flow, and TTM FCF stands at $16.50 billion. That cash engine funded both the buyback and dividend internally, and management raised free-cash-flow guidance — the core of the value-and-return thesis.
Bearish
- Earnings volatility is extreme: Gross margin swung from 7.61% in Q2 2026 to 18.55% in Q3, and Q4 2025 posted a -$3.31 billion net loss with a negative 2.48% gross margin. Trailing net margin of 1.46% and operating margin of 1.57% show how fragile the earnings base is quarter to quarter.
- Leverage and cyclical exposure: Debt-to-equity of 2.13x and a current ratio of 1.17 leave limited cushion, while ROE of 4.41% and ROA of 2.77% are modest for the leverage employed. Revenue is heavily concentrated in GM North America ($41.42 billion of Q3's $50.02 billion), tying results to U.S. truck/SUV demand and pricing.
- Commodity and tariff headwinds: Near-term commodity and tariff pressure is the explicit reason the $75 low analyst target sits essentially at the current price and 52-week low. Skeptics doubt Q3's 18.55% gross margin is sustainable, and the 10.86% trailing gross margin is already below the 12-14% range GM posted through much of 2023-2024.
- Weak price action and high beta: The stock is down 10.49% over three months and 2.80% YTD, sitting at roughly 36% of its 52-week range ($70.25-$93.70). It failed at the $92.43 November 4 peak and dropped 3.72% on 7.44 million shares on November 20, with a beta of 1.418 and a -16.2% max drawdown punishing momentum holders.
GM Technical Analysis
GM is in a choppy, range-bound consolidation rather than a clean trend: the stock is up 15.68% over the past year but down 2.80% YTD, and at $78.71 it sits at roughly 36% of its 52-week range ($70.25 low to $93.70 high) — closer to the lower quartile than the highs. That positioning is neither a momentum breakout nor a capitulation low; it reflects a market that has repeatedly faded rallies into the low $90s while defending the mid-$70s. Notably, the 1-year gain of 15.68% versus SPY's 4.67% implies relative strength of +11.01%, so the longer-term trend is modestly positive even as absolute price action stalls. Recent momentum is bifurcated: the 1-month change is +3.42% (relative strength +13.13% versus a -9.71% SPY month), but the 3-month change is -10.49% and the 6-month change is essentially flat at -0.10%. The stock rallied from $75.80 on July 20 to $92.43 on November 4 (+22% in about 15 weeks), then gave back nearly all of it, closing at $78.71 on November 20 — a -3.72% single-day drop on 7.44 million shares that signals distribution into weakness. This pattern of a sharp 1-month bounce inside a negative 3-month trend looks like mean reversion within a range rather than a durable reversal, and the failure at the November high argues for caution until price reclaims the mid-$80s. Key levels are well defined: support sits at the $70.25 52-week low, with secondary support near the $75.80-$76.00 July/October lows that have been bought twice; resistance is the $93.70 52-week high and the $92.43 November 4 peak. A breakout above $93.70 would confirm a new leg higher and likely force short covering (short ratio 2.44), while a breakdown below $70.25 would invalidate the year's gains and target the prior cycle lows. With a beta of 1.418 — roughly 42% more volatile than SPY — position sizing should be scaled down accordingly, and the -16.2% max drawdown over the period underscores that this name can punish momentum chasers.
Beta
1.42
1.42x market volatility
Max Drawdown
-16.2%
Largest decline past year
52-Week Range
$70-$94
Price range past year
Annual Return
+15.7%
Cumulative gain past year
| Period | GM Return | S&P 500 |
|---|---|---|
| 1m | +3.4% | -9.2% |
| 3m | -10.5% | -9.7% |
| 6m | -0.1% | -8.1% |
| 1y | +15.7% | +4.7% |
| ytd | -2.8% | +1.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
GM Fundamental Analysis
Revenue is growing modestly but unevenly: Q3 2026 revenue of $50.02 billion rose 2.93% year over year from $48.59 billion, continuing a sequential climb from $43.62 billion in Q1 and $48.03 billion in Q2. The mix is heavily North America-centric — GM North America contributed $41.42 billion (or $45.71 billion on the GMNA line) versus just $4.09 billion from GM International and $4.31 billion from GM Financial — meaning U.S. truck/SUV demand and pricing, not international expansion, drive the top line. Growth is therefore low-single-digit and cyclical rather than secular, and the investment case leans on per-unit profitability and capital return rather than revenue acceleration. Profitability is highly volatile quarter to quarter: Q3 2026 net income was $3.34 billion with an 18.55% gross margin and 6.67% net margin, a sharp rebound from Q2's $1.31 billion (7.61% gross margin) and a dramatic swing from the Q4 2025 loss of -$3.31 billion (negative 2.48% gross margin, likely reflecting a large non-cash/impairment charge). The trailing figures — 1.46% net margin and 1.57% operating margin — are depressed by that Q4 loss and understate normalized earning power, while the 10.86% gross margin sits below the 12-14% range GM posted through much of 2023-2024. The key question is whether Q3's 18.55% gross margin is a genuine recovery or a favorable mix/timing artifact; the Q2-to-Q3 swing of more than 1,000 bps in gross margin argues for treating any single quarter with skepticism. The balance sheet is levered but liquid: debt-to-equity is 2.13x, the current ratio is 1.17, and cash stands at $27.02 billion against $7.32 billion of quarterly operating cash flow and $4.97 billion of free cash flow (TTM FCF $16.50 billion). ROE of 4.41% and ROA of 2.77% are modest for the leverage employed, but the cash engine is real — Q3 buybacks of $2.50 billion plus $215 million of dividends were funded internally, and the $20 billion authorization is backed by FCF rather than balance-sheet capacity. The main financial risk is the 2.13x debt-to-equity and auto-cycle sensitivity, not liquidity.
Quarterly Revenue
$50.0B
2026-09
Revenue YoY Growth
+2.9%
YoY Comparison
Gross Margin
18.6%
Latest Quarter
Free Cash Flow
$16.5B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is GM Overvalued?
Because trailing net income is positive but distorted by the Q4 2025 loss, the PE ratio is the appropriate primary metric, though it must be read alongside forward earnings: the trailing PE of 24.42x collapses to a forward PE of 5.35x, an 78% compression that implies the market expects earnings to roughly quadruple versus the trailing base. That gap is less a growth forecast than an artifact of the depressed trailing denominator — consensus EPS of ~$21.59 against a $78.71 price yields the 5.35x forward multiple, which is the more economically meaningful figure. On that basis GM trades at a steep discount to the broader market, and the 0.40x PS ratio and 0.92x EV/Sales reinforce a deep-value profile. Peer comparison is constrained because the provided valuation dataset lacks explicit industry-average multiples, but the internal spreads are telling: 1.22x book, 2.78x price-to-cash-flow, and 9.99x EV/EBITDA are all consistent with a mature, capital-intensive manufacturer trading at a cyclical discount rather than a premium. The 0.88% dividend yield and 24.4% payout ratio leave ample room for the buyback-led return strategy, and the negative PEG ratio (-0.50) is a mathematical artifact of the loss quarter rather than a meaningful signal. Historically, GM's own PE band has been extremely wide — from 3.46x (Q1 2025) and 5.08x (Q3 2026) on the low end to 24.42x currently on a trailing basis — while its PS ratio has ranged from roughly 1.0x to 1.65x over the past three years and now sits at 0.40x, near the bottom of that band. The low PS and PB (1.22x versus a 0.61x-1.42x historical range) suggest the market is pricing in cyclical pessimism and skepticism about earnings durability, which is either a value opportunity or a warning that normalized margins are lower than the Q3 print implies.
PE
24.4x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 3x~8x
vs. Industry Avg
21.9x
Industry PE ~21.9x*
EV/EBITDA
10.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on earnings fragility and leverage. Gross margin swung more than 1,000 bps from 7.61% in Q2 2026 to 18.55% in Q3, and Q4 2025 delivered a -$3.31 billion net loss with a negative 2.48% gross margin, leaving trailing net margin at just 1.46% and operating margin at 1.57%. Debt-to-equity of 2.13x and a current ratio of 1.17 provide limited cushion, while ROE of 4.41% and ROA of 2.77% are thin for the leverage employed. Revenue concentration compounds the risk: GM North America contributed $41.42 billion of Q3's $50.02 billion, so U.S. truck/SUV pricing and volume — not international growth — determine results, and the 2.93% YoY revenue growth is low-single-digit and cyclical. Market and competitive risks include valuation compression and cyclical sensitivity. The 24.42x trailing PE versus 5.35x forward shows how dependent the multiple is on the depressed trailing denominator; if normalized earnings disappoint, the apparent discount evaporates. With a beta of 1.418 — roughly 42% more volatile than SPY — GM is highly exposed to macro and sector rotation, and the stock's failure at the $92.43 November 4 peak followed by a -3.72% single-day drop on 7.44 million shares signals distribution. Competitive pressure from Toyota, Ford, Stellantis, and a rising wave of EV entrants, plus the strategic retreat from robotaxi operations toward personal AVs, adds execution uncertainty. The worst-case scenario is a margin normalization toward the 10.86% trailing gross margin coinciding with commodity/tariff cost pressure and a cyclical U.S. demand slowdown, which would compress forward EPS well below the ~$21.59 consensus and force multiple de-rating. In that chain, the stock would retest the $70.25 52-week low — roughly -10.7% from $78.71 — and a break below it would invalidate the year's gains and target prior cycle lows, consistent with the -16.2% max drawdown already experienced. The $75 analyst low target sits essentially at the current price, offering no downside cushion, so a realistic adverse outcome is a -10% to -20% loss from current levels.
FAQ
Ranked by severity, the first risk is earnings fragility: gross margin swung from 7.61% in Q2 2026 to 18.55% in Q3, and Q4 2025 produced a -$3.31 billion net loss with a negative 2.48% gross margin, leaving trailing net margin at just 1.46%. Second is financial leverage and cyclical concentration: debt-to-equity of 2.13x with a 1.17 current ratio leaves limited cushion, and GM North America contributed $41.42 billion of Q3's $50.02 billion, tying results to U.S. truck/SUV pricing and demand. Third is cost and policy pressure — commodity and tariff headwinds are the explicit reason the $75 low target sits at the current price, and the 10.86% trailing gross margin is already below the 12-14% range of much of 2023-2024. Fourth is market sensitivity: a beta of 1.418 means roughly 42% more volatility than SPY, and the stock has already absorbed a -16.2% max drawdown, so sector rotation or a broad market pullback would be amplified.
The 12-month distribution is centered on the base case (50% probability, $95-$105), which assumes gross margin normalizes into the 12-15% band, low-single-digit revenue growth consistent with Q3's +2.93% YoY, and free cash flow near the $16.50 billion TTM level sustaining the buyback — producing roughly +28.5% to the $101.17 average target. The bull case (25%, $110-$132) requires Q3's 18.55% gross margin to hold above 15% for a second consecutive quarter while the $20 billion buyback compounds EPS and the market re-rates GM toward 6-7x forward earnings, bracketing the $132 high target. The bear case (25%, $70-$75) is a margin reversion toward 10.86% coinciding with commodity/tariff pressure and a U.S. demand slowdown, retesting the $70.25 52-week low. The base case is most likely, and its key assumption is margin durability in the 12-15% band — the single variable that separates the bull and bear outcomes.
GM screens as undervalued on forward earnings and on its own history, though the trailing multiple tells a misleading story. The 24.42x trailing PE is inflated by the Q4 2025 loss and collapses to 5.35x forward, an ~78% compression that reflects the depressed trailing denominator rather than a growth forecast. On sales, 0.40x PS and 0.92x EV/Sales sit near the bottom of GM's roughly 1.0x-1.65x three-year PS band, and 1.22x book is within but toward the lower half of its 0.61x-1.42x historical range, while 9.99x EV/EBITDA is consistent with a mature manufacturer at a cyclical discount. The market is therefore paying a discount, not a premium, and implicitly expects normalized margins to be closer to the 10.86% trailing gross margin than to Q3's 18.55% print. If that skepticism is wrong, the re-rating toward 6-7x forward earnings implied by the bull case is the source of return; if it is right, the apparent cheapness is a value trap.
From a risk/reward standpoint the setup is asymmetric but not one-sided: at $78.71 the stock trades at 5.35x forward earnings on ~$21.59 consensus EPS, with the $101.17 average analyst target implying +28.5% upside and 20 of 23 analysts rating Buy with zero Sells. The downside anchor is uncomfortably close, however — the $75 analyst low target sits essentially at the current price and the $70.25 52-week low is only about -10.7% away, so the margin of safety rests on earnings durability rather than on the price level. The biggest risk is that Q3's 18.55% gross margin proves a mix/timing artifact and reverts toward the 10.86% trailing level, which would undercut the forward EPS base that justifies the multiple. It is a reasonable buy for value-oriented investors with a multi-quarter horizon who can tolerate a 1.418 beta and a -16.2% max drawdown, ideally accumulated on weakness toward the mid-$70s; it is a poor fit for momentum traders given the -10.49% three-month decline and repeated failures in the low $90s.
GM fits a medium-to-long-term holding profile rather than a trading vehicle. The thesis is built on capital return compounding — a $20 billion buyback authorization, a share count down ~40% since 2023, and a 12.6% total shareholder yield versus Ford's ~5.7% — which requires multiple quarters to translate into EPS, and the 0.88% dividend yield with a modest 24.4% payout ratio adds a small income component. Earnings visibility is low quarter to quarter given the 7.61%-to-18.55% gross margin swing and the Q4 2025 loss, and the 1.418 beta plus -16.2% max drawdown mean short-term price action is dominated by macro and sector rotation rather than fundamentals. A concrete minimum holding period of 12-18 months is appropriate, spanning at least two earnings cycles to confirm margin durability, with position sizing scaled down for the high beta and entry staged toward the $75-$76 support shelf rather than chased above the low $90s.

